» Articles » PMID: 31293324

Establishing an Anti-Müllerian Hormone Cutoff for Diagnosis of Polycystic Ovarian Syndrome in Women of Reproductive Age-Bearing Indian Ethnicity Using the Automated Anti-Müllerian Hormone Assay

Overview
Date 2019 Jul 12
PMID 31293324
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Polycystic ovary syndrome diagnosed by Rotterdam criteria, is the most common cause of anovulatory infertility. The criteria of polycystic ovarian morphology (PCOM) are subject to operator variability and technological advances. Serum anti-Müllerian hormone (AMH) level has been proposed as a more reliable alternative to antral follicle count. There is a paucity of data on use of AMH for diagnosis of PCOS in Indian women.

Aim And Objectives: The aim of this study is to determine a cutoff level for AMH that could facilitate diagnosis of PCOS and its phenotypes in women of Indian origin using the automated (Roche) assay and to compare the competence of oocytes in PCOS and non-PCOS women undergoing fertilization-intracytoplasmic sperm injection (IVF-ICSI).

Materials And Methodology: A total of 367 women undergoing treatment at our fertility center between February 2017 and August 2017 were prospectively enrolled in this study. Of these, 133 were diagnosed with PCOS, 69 had isolated PCOM, and 165 (controls) had normal ovaries on ultrasound examination. Serum AMH levels were assessed using the fully automated Roche Elecsys immunoassay. Gonadotropin-releasing hormone antagonist protocol was used for IVF-ICSI in all patients.

Statistical Analysis Used: Quantitative variables were compared using the Mann-Whitney test. Qualitative variables were correlated using the Chi-square test. < 0.05 was considered to be statistically significant.

Results: Mean AMH concentrations in women with PCOS was higher (7.56 ± 4.36 ng/mL) in comparison to PCOM and controls. Serum AMH concentration >5.03 ng/mL could facilitate diagnosis of PCOS (area under the curve = 0.826); sensitivity -70.68%, specificity of 79.91%. There was no difference in the ratio of mature to total oocytes retrieved in the three groups ( > 0.05). Mean number of mature oocytes was lower in controls than PCOS and PCOM ( < 0.001).

Conclusions: Serum AMH concentration >5.03 ng/mL could be used as cutoff value for the diagnosis of PCOS in women of Indian origin.

Citing Articles

Diagnostic Utility of Various Hormones across Different Polycystic Ovary Syndrome Phenotypes: A Cross-sectional Study.

Ravi Kumar P, Telagareddy R, Dash D, Patro D J Hum Reprod Sci. 2025; 17(4):275-283.

PMID: 39831099 PMC: 11741125. DOI: 10.4103/jhrs.jhrs_152_24.


The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome.

Sivanandy M, Ha S Diagnostics (Basel). 2023; 13(5).

PMID: 36900051 PMC: 10000702. DOI: 10.3390/diagnostics13050907.


Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective.

Jirge P, Patil M, Gutgutia R, Shah J, Govindarajan M, Roy V J Hum Reprod Sci. 2022; 15(2):112-125.

PMID: 35928474 PMC: 9345274. DOI: 10.4103/jhrs.jhrs_59_22.


Anti-Müllerian Hormone Predictive Levels to Determine The Likelihood of Ovarian Hyper-Response in Infertile Women with Polycystic Ovarian Morphology.

Akbari Sene A, Ashrafi M, Alaghmand-Fard N, Mohammadi N, Mortezapour Alisaraie M, Alizadeh A Int J Fertil Steril. 2021; 15(2):115-122.

PMID: 33687164 PMC: 8052798. DOI: 10.22074/IJFS.2020.134614.

References
1.
Ludwig M, Finas D, Al-Hasani S, Diedrich K, Ortmann O . Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod. 1999; 14(2):354-8. DOI: 10.1093/humrep/14.2.354. View

2.
Teissier M, Chable H, Paulhac S, Aubard Y . Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Hum Reprod. 2000; 15(12):2471-7. DOI: 10.1093/humrep/15.12.2471. View

3.
Mikkelsen A, Lindenberg S . Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality. Hum Reprod. 2001; 16(8):1714-8. DOI: 10.1093/humrep/16.8.1714. View

4.
Cook C, Siow Y, Brenner A, Fallat M . Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002; 77(1):141-6. DOI: 10.1016/s0015-0282(01)02944-2. View

5.
Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S . Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003; 88(12):5957-62. DOI: 10.1210/jc.2003-030727. View